- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.10. | Novo plant hit with FDA's most serious inspection classification, portending possible delays for partners | ||
| 13.10. | BMS cooks up schizophrenia stigma-busting initiative with 'Top Chef' judge Gail Simmons | ||
| 13.10. | FDA adds warning to label of J&J, Legend's Carvykti for potentially fatal intestinal disorder | ||
| 13.10. | German drug delivery specialist LTS grows US footprint with buyout of CDMO Renaissance Lakewood | ||
| 10.10. | Novo shutters cell therapy unit, ending work on potential Type 1 diabetes 'cure' | ||
| 10.10. | AstraZeneca to visit White House to formalize MFN agreement with Trump, MSNBC reports | ||
| 10.10. | Gilead's Yeztugo, Eisai's Leqembi Iqlik, Vertex's Journavx among 2025's best inventions: Time | ||
| 10.10. | Swiss auto-injector specialist Ypsomed invests $248M to build manufacturing facility in NC | ||
| 10.10. | Senate endorses Biosecure Act successor, adopting softer tone and omitting WuXi companies | ||
| 10.10. | Fierce Pharma Asia-TROP2 showdown; InnoCare, Zenas' $2B autoimmune deal; Lupin's US investment | ||
| 10.10. | Pelthos rolls out Zelsuvmi with campaign aimed at moms who 'don't mess around' | ||
| 09.10. | Planned summit hosted by DTC specialist BlinkRx raises concerns over ties to Trump admin: WSJ | ||
| 09.10. | AstraZeneca kicks off construction of $4.5B API plant in Virginia | ||
| 09.10. | Regeneron's Libtayo gains 'practice-changing' skin cancer label expansion | ||
| 09.10. | Lilly sponsors 'Project Runway' challenge to boost eczema's representation in pop culture | ||
| 09.10. | Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla. | ||
| 08.10. | Ferring to reduce global headcount by 500 as part of reorganization | ||
| 08.10. | Vanda signs on as NHL's 1st pharma patch sponsor in Islanders deal, inks DC arena partnership | ||
| 08.10. | Zenas makes big bet on MS drug, striking $2B licensing deal with InnoCare | ||
| 08.10. | UK floats plan to fend off Trump tariffs by raising NHS drug spending threshold: Politico | ||
| 08.10. | Vifor to cut 55 jobs as parent company CSL pushes ahead with downsizing, savings drive | ||
| 08.10. | Galderma's Nemluvio itch relief claims scratched after Sanofi complaint | ||
| 07.10. | After high-profile FDA exit, Peter Marks lands at Eli Lilly | ||
| 07.10. | Novartis survey shines a light on hidden realities of women's conversations about breast health | ||
| 07.10. | Jury orders J&J to pay $966M in baby powder lawsuit |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .